What is Pliant Therapeutics, Inc. Common Stock's Market Cap?

Pliant Therapeutics, Inc. Common Stock's Market Cap is $71.2M, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's Enterprise Value?

Pliant Therapeutics, Inc. Common Stock's Enterprise Value is -$86.9M, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's EV / EBITDA?

Pliant Therapeutics, Inc. Common Stock's EV / EBITDA is 0.9×, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's Revenue (TTM)?

Pliant Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's Net Income (TTM)?

Pliant Therapeutics, Inc. Common Stock's Net Income (TTM) is -$92.3M, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's EBITDA?

Pliant Therapeutics, Inc. Common Stock's EBITDA is -$96.2M, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Pliant Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.49, based on as-reported figures from SEC (XBRL) filings.

What is Pliant Therapeutics, Inc. Common Stock's Net Debt?

Pliant Therapeutics, Inc. Common Stock's Net Debt is -$158.1M, based on as-reported figures from SEC (XBRL) filings.

Pliant Therapeutics, Inc. Common Stock (PLRX) Financial Statements

Pliant Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00C8083P2

XNAS · usd

1.15▲ 0.01 (1.32%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.14

Day's Range1.11 – 1.18

52-Week Range1.02 – 1.95

Volume682.9K

Avg Volume398.0K

Share Statistics

Shares Outstanding

Employees49

ExchangeXNAS

Listed2020-06-03

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Pliant Therapeutics, Inc. Common Stock (PLRX)

What is Pliant Therapeutics, Inc. Common Stock's Market Cap?: Pliant Therapeutics, Inc. Common Stock's Market Cap is $71.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's Enterprise Value?: Pliant Therapeutics, Inc. Common Stock's Enterprise Value is -$86.9M, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's EV / EBITDA?: Pliant Therapeutics, Inc. Common Stock's EV / EBITDA is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's Revenue (TTM)?: Pliant Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's Net Income (TTM)?: Pliant Therapeutics, Inc. Common Stock's Net Income (TTM) is -$92.3M, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's EBITDA?: Pliant Therapeutics, Inc. Common Stock's EBITDA is -$96.2M, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Pliant Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.49, based on as-reported figures from SEC (XBRL) filings.
What is Pliant Therapeutics, Inc. Common Stock's Net Debt?: Pliant Therapeutics, Inc. Common Stock's Net Debt is -$158.1M, based on as-reported figures from SEC (XBRL) filings.